Compounded tirzepatide is a medication that may be prepared by licensed compounding pharmacies and is intended to function as a dual GLP-1/GIP receptor agonist medication. Dual GLP-1/GIP receptor agonists are designed to interact with both GLP-1 and GIP receptors, which are naturally found throughout the body and are involved in various physiological processes, including glucose metabolism and gastrointestinal function. Dual GLP-1/GIP receptor agonists can help regulate blood sugar and appetite control.
Compounded tirzepatide has not been approved by the FDA and is not equivalent to any FDA-approved products.
Prescribers typically follow a dosing schedule that resembles the following:
Month 1 (weeks 1-4): 2.5mg/week
Month 2 (weeks 5-8): 5.0mg/week
Month 3 (weeks 9-12): 7.5mg/week
Month 4 (weeks 13-16): 10mg/week
Month 5+ (week 16+): 12.5mg/week
Month 6+ (weeks 16+): 15mg/week
Many patients decide to maintain on a weekly dose below the maximum dose of 15mg throughout their course of therapy.
This is not medical advice. The dosages provided are for informational purposes only and do not replace professional medical guidance. Each patient is unique, and physicians determine prescriptions based on individual medical needs. Always consult your physician to determine the appropriate titration schedule and medication.
Coby Health believes in flexibility and transparency. Our pricing structure is designed to ensure there are no hidden fees or surprises in your costs.
Compounded tirzepatide is not reviewed or approved by the FDA for safety or effectiveness. Compounded tirzepatide is not a generic form of Mounjaro® or Zepbound®. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly. Coby has no affiliation with Eli Lilly. See Important Safety Information.
Compounded tirzepatide is not reviewed or approved by the FDA for safety or effectiveness. Compounded tirzepatide is not a generic form of Mounjaro® or Zepbound®. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly. Coby has no affiliation with Eli Lilly. See Important Safety Information.
Compounded tirzepatide is not reviewed or approved by the FDA for safety or effectiveness. Compounded tirzepatide is not a generic form of Mounjaro® or Zepbound®. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly. Coby has no affiliation with Eli Lilly. See Important Safety Information.
Compounded tirzepatide is not reviewed or approved by the FDA for safety or effectiveness. Compounded tirzepatide is not a generic form of Mounjaro® or Zepbound®. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly. Coby has no affiliation with Eli Lilly. See Important Safety Information.
Compounded tirzepatide is not reviewed or approved by the FDA for safety or effectiveness. Compounded tirzepatide is not a generic form of Mounjaro® or Zepbound®. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly. Coby has no affiliation with Eli Lilly. See Important Safety Information.
Compounded tirzepatide is not reviewed or approved by the FDA for safety or effectiveness. Compounded tirzepatide is not a generic form of Mounjaro® or Zepbound®. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly. Coby has no affiliation with Eli Lilly. See Important Safety Information.
Compounded tirzepatide is not reviewed or approved by the FDA for safety or effectiveness. Compounded tirzepatide is not a generic form of Mounjaro® and Zepbound®.Mounjaro® and Zepbound® are registered trademarks of Eli Lilly. Coby has no affiliation with Eli Lilly. See Important Safety Information.
Lorem ipsum dolor sit amet, consectetur adipiscing elit id venenatis pretium risus euismod dictum egestas orci netus feugiat ut egestas ut sagittis tincidunt phasellus elit etiam cursus orci in. Id sed montes.
Lorem ipsum dolor sit amet, consectetur adipiscing elit id venenatis pretium risus euismod dictum egestas orci netus feugiat ut egestas ut sagittis tincidunt phasellus elit etiam cursus orci in. Id sed montes.
Lorem ipsum dolor sit amet, consectetur adipiscing elit id venenatis pretium risus euismod dictum egestas orci netus feugiat ut egestas ut sagittis tincidunt phasellus elit etiam cursus orci in. Id sed montes.
Lorem ipsum dolor sit amet, consectetur adipiscing elit id venenatis pretium risus euismod dictum egestas orci netus feugiat ut egestas ut sagittis tincidunt phasellus elit etiam cursus orci in. Id sed montes.
Lorem ipsum dolor sit amet, consectetur adipiscing elit id venenatis pretium risus euismod dictum egestas orci netus feugiat ut egestas ut sagittis tincidunt phasellus elit etiam cursus orci in. Id sed montes.
Our online visit will guide you through the process to connect with a doctor.
Upon approval, your clinician will provide a personalized treatment plan.
Your medication for your weight loss* plan will be delivered to your doorstep.
*Individual results from adding a compounded GLP-1 medication to your weight loss regimen will vary.
Compounded tirzepatide, a dual GLP-1/GIP receptor agonist medication is formulated to target the GLP-1 and GIP receptors in your body. With no-wait consultations and free shipping upon approval, Coby users have the most straightforward experience possible.
Your provider will gradually increase your compounded tirzepatide dose to provide the best results and minimize side effects.
At Coby, we strive to provide transparent pricing to make compounded tirzepatide both affordable and predictable.
GLP-1 receptor agonist medication
Choose from monthly (cancel anytime) and quarterly packages
Includes at-home injection kit (alcohol pads and syringes)
Product images are for illustration only. Actual product will vary. Compounded semaglutide is not reviewed or approved by the FDA for safety or effectiveness. Compounded semaglutide is not a generic form of Ozempic® and Wegovy®. Ozempic® and Wegovy® are registered trademarks of Novo Nordisk. Coby Health has no affiliation with Novo Nordisk. See Important Safety Information.
